Parkinson's disease is a neurodegenerative disorder characterized mainly by a loss of the dopaminergic neurons of the nigrostriatal pathway. The symptomatic treatment, which consists of the supply of the deficient neurotransmitter dopamine, does not, however, prevent the progression of the disease and is frequently associated with major motor and psychiatric side effects. Recent basic and clinical investigations have led to the development of new therapeutical strategies for Parkinson's disease. The authors review and describe these new approaches which include: [1] treatments aimed at slowing down the progression of the disease, [2] treatments aimed at decreasing the motor side effects and [3] the use of intracerebral transplantations
Parkinson’s disease (PD) is the second most common neurodegenerative illness that affects the centra...
Parkinson's disease in a neurodegenerative disorder that affects as many as 1-2 % of persons aged 60...
Parkinson's disease is the second most common neurodegenerative disorder. It is characterised by a t...
Parkinson's disease is a neurodegenerative disorder characterized mainly by a loss of the dopaminerg...
Parkinson's disease is a neurodegenerative disorder characterized mainly by a loss of the dopaminerg...
Parkinson’s disease (PD) is a common neurodegenerative disorder of the brain and typically presents ...
Parkinson's disease (PD) is a common neurodegenerative disease typified by a movement disorder consi...
Biotherapies in neurosurgery : an example in Parkinson’s disease. Parkinson disease (PD) is mainly ...
L-DOPA remains the mainstay of therapy for Parkinson's disease (PD). However, the side-effects asso...
L-DOPA remains the mainstay of therapy for Parkinson's disease (PD). However, the side-effects asso...
Parkinson's disease (PD) is characterised clinically by various non-motor and progressive motor symp...
Parkinson disease (PD) is an age-related neurodegenerative disorder that affects as many as 1–2 % of...
L-DOPA remains the mainstay of therapy for Parkinson's disease (PD). However, the side-effects asso...
L-DOPA remains the mainstay of therapy for Parkinson's disease (PD). However, the side-effects asso...
Parkinson’s disease (PD) is the second most common neurodegenerative illness that affects the centra...
Parkinson’s disease (PD) is the second most common neurodegenerative illness that affects the centra...
Parkinson's disease in a neurodegenerative disorder that affects as many as 1-2 % of persons aged 60...
Parkinson's disease is the second most common neurodegenerative disorder. It is characterised by a t...
Parkinson's disease is a neurodegenerative disorder characterized mainly by a loss of the dopaminerg...
Parkinson's disease is a neurodegenerative disorder characterized mainly by a loss of the dopaminerg...
Parkinson’s disease (PD) is a common neurodegenerative disorder of the brain and typically presents ...
Parkinson's disease (PD) is a common neurodegenerative disease typified by a movement disorder consi...
Biotherapies in neurosurgery : an example in Parkinson’s disease. Parkinson disease (PD) is mainly ...
L-DOPA remains the mainstay of therapy for Parkinson's disease (PD). However, the side-effects asso...
L-DOPA remains the mainstay of therapy for Parkinson's disease (PD). However, the side-effects asso...
Parkinson's disease (PD) is characterised clinically by various non-motor and progressive motor symp...
Parkinson disease (PD) is an age-related neurodegenerative disorder that affects as many as 1–2 % of...
L-DOPA remains the mainstay of therapy for Parkinson's disease (PD). However, the side-effects asso...
L-DOPA remains the mainstay of therapy for Parkinson's disease (PD). However, the side-effects asso...
Parkinson’s disease (PD) is the second most common neurodegenerative illness that affects the centra...
Parkinson’s disease (PD) is the second most common neurodegenerative illness that affects the centra...
Parkinson's disease in a neurodegenerative disorder that affects as many as 1-2 % of persons aged 60...
Parkinson's disease is the second most common neurodegenerative disorder. It is characterised by a t...